CAMPAGNA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 1.786
EU - Europa 1.216
AS - Asia 704
SA - Sud America 125
AF - Africa 34
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.869
Nazione #
US - Stati Uniti d'America 1.773
IT - Italia 389
SG - Singapore 278
HK - Hong Kong 180
CN - Cina 172
RU - Federazione Russa 157
IE - Irlanda 137
BR - Brasile 120
SE - Svezia 99
DE - Germania 85
UA - Ucraina 75
FR - Francia 59
FI - Finlandia 50
GB - Regno Unito 35
AT - Austria 33
NL - Olanda 32
CI - Costa d'Avorio 24
DK - Danimarca 20
IN - India 19
KR - Corea 19
RO - Romania 12
TR - Turchia 12
CA - Canada 10
BE - Belgio 7
JP - Giappone 7
PL - Polonia 6
CZ - Repubblica Ceca 4
HR - Croazia 4
MA - Marocco 4
SM - San Marino 4
AU - Australia 3
BD - Bangladesh 3
LT - Lituania 3
ID - Indonesia 2
MX - Messico 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
TH - Thailandia 2
TW - Taiwan 2
ZA - Sudafrica 2
BG - Bulgaria 1
BJ - Benin 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
ES - Italia 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 3.869
Città #
Chandler 275
Singapore 186
Hong Kong 179
Des Moines 144
Dublin 137
Ashburn 135
Boardman 132
Fairfield 100
Jacksonville 84
Ancona 65
Seattle 58
Wilmington 50
Turin 49
New York 46
Houston 40
The Dalles 39
Moscow 38
Woodbridge 37
Lawrence 35
Princeton 35
Cambridge 34
Centro 32
Ann Arbor 28
Beijing 26
Tolentino 25
Abidjan 24
San Mateo 23
Turku 23
Vienna 23
Washington 22
Munich 21
Shanghai 20
Helsinki 19
Milan 19
San Diego 19
Aversa 16
Nuremberg 16
Rome 16
Redmond 15
London 13
Los Angeles 13
Wuhan 13
Brasov 12
Guangzhou 10
Marche 10
Dallas 9
Pune 9
Rieti 9
Boydton 7
Brussels 7
Hangzhou 7
Cagliari 6
Curitiba 6
Istanbul 6
Maringá 6
Pittsburgh 6
San Francisco 6
Wuxi 6
Chicago 5
Jiaxing 5
Jinhua 5
Perugia 5
Pesaro 5
São Paulo 5
Belo Horizonte 4
Borgo Maggiore 4
Chennai 4
Civitanova Marche 4
Falconara Marittima 4
Iesi 4
Naples 4
Pavia 4
Radomsko 4
Toronto 4
Zagreb 4
Zibo 4
Andover 3
Brooklyn 3
Columbus 3
Manassas 3
Manchester 3
Marigliano 3
Montelupone 3
Namhyang-dong 3
Olomouc 3
Quanzhou 3
Redwood City 3
Shenzhen 3
Stockholm 3
São Bernardo do Campo 3
Yiwu 3
Amsterdam 2
Anaheim 2
Ascoli Piceno 2
Asunción 2
Atlanta 2
Bangkok 2
Bhubaneswar 2
Bielefeld 2
Boston 2
Totale 2.587
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 225
Nicotinamide N-Methyltransferase Inhibition in Endothelium: Effect on Cell Viability and Respiration 130
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 130
Clinical performance and utility of a NNMT-based urine test for bladder cancer 123
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 120
Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation 99
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 97
Molecular analysis of endometrial inflammation in preterm birth 92
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 89
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 87
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 80
Overexpression of Nicotinamide N-Methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation 77
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 74
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 73
Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT) 73
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 70
Actin-spectrin scaffold supports open fenestrae in liver sinusoidal endothelial cells 70
Nicotinamide N-methyltransferase gene silencing in endothelial cell lines: molecular and phenotypic characterization 69
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 68
Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside 68
Bardoxolone Methyl Displays Detrimental Effects on Endothelial Bioenergetics, Suppresses Endothelial ET-1 Release, and Increases Endothelial Permeability in Human Microvascular Endothelium 68
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 67
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 67
Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity 67
C. spinosa L. subsp. rupestris Phytochemical Profile and Effect on Oxidative Stress in Normal and Cancer Cells 65
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 65
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 65
PON2 silencing to evaluate the effectiveness of Cisplatin treatment in OSCC cells by FTIRM analyses 64
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 62
Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury 62
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 61
Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics 61
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 61
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 58
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 58
Nicotinamide N-methyltransferase inhibition in endothelial cell lines: effect on the cellular phenotype, cell viability and bioenergetic balance 57
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 56
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 55
Nicotinamide N-methyltransferase inhibition in endothelium: effect on the cellular phenotype, viability and bio-energetics 54
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 52
Effect of nicotinamide N-methyltransferase gene silencing on endothelial bioenergetics. 50
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 48
NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health 45
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 45
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 44
Paraoxonase-2 expression in oral squamous cell carcinoma 43
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 42
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 42
Paraoxonase-2 (PON2) is upregulated in triple negative breast cancer and contributes to the tumor progression and chemoresistance 40
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 40
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 40
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 38
The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update 37
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 37
Nicotinamide N-methyltransferase: a key enzyme of pyridine metabolism and a target for human osteosarcoma treatment 36
In Vitro Study of the Proliferation of MG63 Cells Cultured on Five Different Titanium Surfaces 36
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 35
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 35
Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma. 34
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 32
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 31
Exploring the role of paraoxonase-2 in human clear cell renal cell carcinoma: in vitro effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 30
Role of nicotinamide N-methyltransferase in human osteosarcoma: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 27
The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges 26
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 24
The Multifaceted Role of the Polyphenol Curcumin: A Focus on Type 2 Diabetes Mellitus 24
Novel Ti6Al4V Surface Treatment for Subperiosteal Dental Implants: Evaluation of Osteoblast-like Cell Proliferation and Osteogenic Response 18
Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies 15
Totale 4.133
Categoria #
all - tutte 26.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 0 22
2020/2021360 15 20 29 1 21 70 79 14 23 27 43 18
2021/2022359 17 59 40 4 0 19 12 59 9 14 45 81
2022/2023921 55 87 63 81 54 214 13 58 182 7 73 34
2023/2024771 98 16 57 66 105 113 10 18 15 95 36 142
2024/20251.412 155 74 78 38 72 32 134 69 249 160 192 159
Totale 4.133